Equillium

EQNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$120.158 M

$1.90 -1.30%

Close of 21 Sept 2026

Revenue

$41.1M

#2793 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

63,408,082

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#296ProMIS NeurosciencesPMN$122.2M
#297Aardvark TherapeuticsAARD$121.9M
#298EquilliumEQ$120.2M
#299Coya TherapeuticsCOYA$116.1M
#300GeneluxGNLX$115.8M

What if Equillium were worth as much as…

Open the what-if tool →

Gold $30.3T

$477,447.88

Per share 251,951× higher

Bitcoin $1.72T

$27,122.78

Per share 14,313× higher

Nvidia $5.48T

$86,422.07

Per share 45,605× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Equillium are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.